100% Secure Payments
Tender Details
- Country: Hungary
- Summary: Itemized Accounted and other Active Ingredients
- KZT Ref No: 117490231
- Deadline: 12 May 2025
- Competition: ICB
- Financier: Self Financed
- Purchaser Ownership: Public
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 232139-2025
- Purchaser's Detail :
- Description :
- Purchase of the active ingredients of expired patent protection, as well as lapatinib and Durvvalumab active ingredients, is subject to the conclusion of the framework agreement, the Kbt. 105 (1) (a) of the Framework Agreement, further extensionwith the opportunity. The subject of this procurement procedure (in part): Part 1: Rituximab IV. (Oeno: 06058): Total amount: 24 000 000 mg (basic amount: 18,000 000 mg + 6 000 000 mg option) Part 2: Ustkinumab (Oeno: 06056): Total frame quantity: 2 948 400 mg (basic amount: 2 211 300 mg +737 100 mg option) Part 3: Lapatinib (Oeno: 06061): Total frame quantity: 9,030 000 mg (basic amount: 6,020 000 mg + 3 010 000 mg option) Part 4: Durvalumab (Oeno: 06048): Total frame quantity: 8 550 000 mg MG Option) affected patient circle: The active ingredient ustkinumabIn the indications specified in the technical description, all patients are treated in the other active ingredients. The Kbt. In view of Article 73 (6) (c), the Contracting Authority draws the attention of the tenderers to all parts that the tender is invalid to be invalidThe offer, which contains a higher bid than: - for part 1 (rituximab): The last publicly available framework agreement (https://kekeo.kore.kore.kozjerzs.hu/megteses/202713/) for the rituximab active ingrediente...
- Documents :
Purchaser : NATIONAL HEALTH INSURANCE FUND
Address: Vaci ut 73/A
Town: Budapest
NUTS-CODE: HU110
Postal code: 1139
attn: Gabor Beleznai
Phone: +36 12982509
Fax: +36 1298 ...
Email :beleznaig@neak.gov.hu
URL :https://www.neak.gov.hu
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN
